{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:20:59Z","timestamp":1785799259488,"version":"3.56.0"},"reference-count":41,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2018,3,24]],"date-time":"2018-03-24T00:00:00Z","timestamp":1521849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Alzheimer\u2019s Disease"],"published-print":{"date-parts":[[2018,3,27]]},"abstract":"<jats:p>Abnormal amyloid-\u03b2 (A\u03b2) aggregates are a striking feature of Alzheimer\u2019s disease (AD), and A\u03b2 oligomers have been proven to be crucial in the pathology of AD. Any intervention targeting the generation or aggregation of A\u03b2 can be expected to be useful in AD treatment. Oxidative stress and inflammation are common pathological changes in AD that are involved in the generation and aggregation of A\u03b2. In the present study, 6-month-old PS1V97L transgenic (Tg) mice were treated with sulforaphane, an antioxidant, for 4 months, and this treatment significantly inhibited the generation and aggregation of A\u03b2. Sulforaphane also alleviated several downstream pathological changes that including tau hyperphosphorylation, oxidative stress, and neuroinflammation. Most importantly, the cognition of the sulforaphane-treated PS1V97L Tg mice remained normal compared to that of wild-type mice at 10 months of age, when dementia typically emerges in PS1V97L Tg mice. Pretreating cultured cortical neurons with sulforaphane also protected against neuronal injury caused by A\u03b2 oligomers in vitro. These findings suggest that sulforaphane may be a potential compound that can inhibit A\u03b2 oligomer production in AD.<\/jats:p>","DOI":"10.3233\/jad-171110","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T15:51:12Z","timestamp":1522165872000},"page":"1803-1813","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":81,"title":["Sulforaphane Inhibits the Generation of Amyloid-\n                    <i>\u03b2<\/i>\n                    Oligomer and Promotes Spatial Learning and Memory in Alzheimer\u2019s Disease (PS1V97L) Transgenic Mice"],"prefix":"10.1177","volume":"62","author":[{"given":"Ting-Ting","family":"Hou","sequence":"first","affiliation":[{"name":"Department of Neurology, Inovation Center for Neurological Disorders, Xuan Wu Hospital, Capital Medical University, Beijing, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-Yun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Inovation Center for Neurological Disorders, Xuan Wu Hospital, Capital Medical University, Beijing, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Inovation Center for Neurological Disorders, Xuan Wu Hospital, Capital Medical University, Beijing, P.R. China"},{"name":"Beijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, P.R. China"},{"name":"Clinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, P.R. China"},{"name":"Center of Alzheimer\u2019s Disease, Beijing Institute for Brain Disorders, Beijing, P.R. China"},{"name":"Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-Qi","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Inovation Center for Neurological Disorders, Xuan Wu Hospital, Capital Medical University, Beijing, P.R. China"},{"name":"Beijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, P.R. China"},{"name":"Clinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, P.R. China"},{"name":"Center of Alzheimer\u2019s Disease, Beijing Institute for Brain Disorders, Beijing, P.R. China"},{"name":"Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Ruhua","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Neurology, Inovation Center for Neurological Disorders, Xuan Wu Hospital, Capital Medical University, Beijing, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ping","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Neurology, Inovation Center for Neurological Disorders, Xuan Wu Hospital, Capital Medical University, Beijing, P.R. China"},{"name":"Beijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, P.R. China"},{"name":"Clinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, P.R. China"},{"name":"Center of Alzheimer\u2019s Disease, Beijing Institute for Brain Disorders, Beijing, P.R. China"},{"name":"Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2018,3,24]]},"reference":[{"key":"ref001","doi-asserted-by":"publisher","DOI":"10.1126\/science.1072994"},{"key":"ref002","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3505"},{"key":"ref003","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22248"},{"key":"ref004","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.2016.1146678"},{"key":"ref005","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2011.07478.x"},{"key":"ref006","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt062"},{"key":"ref007","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2013.03.002"},{"key":"ref008","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2013.10.085"},{"key":"ref009","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt108"},{"key":"ref010","doi-asserted-by":"publisher","DOI":"10.1021\/ja054041c"},{"key":"ref011","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10-155317"},{"key":"ref012","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-160673"},{"key":"ref013","doi-asserted-by":"publisher","DOI":"10.2174\/1872214809666150505164138"},{"key":"ref014","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2015.10.016"},{"key":"ref015","doi-asserted-by":"publisher","DOI":"10.3390\/ijms150814396"},{"key":"ref016","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085885"},{"key":"ref017","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2011.07489.x"},{"key":"ref018","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70276-X"},{"key":"ref019","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2013.06.005"},{"key":"ref020","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/415078"},{"key":"ref021","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3028"},{"key":"ref022","doi-asserted-by":"publisher","DOI":"10.1038\/nm1782"},{"key":"ref023","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-015-1386-3"},{"key":"ref024","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3817-03.2004"},{"key":"ref025","doi-asserted-by":"publisher","DOI":"10.3390\/antiox6030065"},{"key":"ref026","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-0009-x"},{"key":"ref027","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2016.11.005"},{"key":"ref028","doi-asserted-by":"publisher","DOI":"10.1021\/bi061853s"},{"key":"ref029","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-007-0697-5"},{"key":"ref030","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.279208"},{"key":"ref031","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2007.05072.x"},{"key":"ref032","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145711000149"},{"key":"ref033","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2010-1222"},{"key":"ref034","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.7007"},{"key":"ref035","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0172-12.2012"},{"key":"ref036","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aal2021"},{"key":"ref037","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2016.02.002"},{"key":"ref038","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2012.06.033"},{"key":"ref039","first-page":"146","volume":"2","author":"Tai HC","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"ref040","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.06.036"},{"key":"ref041","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2010.11.030"}],"container-title":["Journal of Alzheimer\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JAD-171110","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3233\/JAD-171110","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JAD-171110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:06:08Z","timestamp":1777370768000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3233\/JAD-171110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,24]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,3,27]]}},"alternative-id":["10.3233\/JAD-171110"],"URL":"https:\/\/doi.org\/10.3233\/jad-171110","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,24]]}}}